The Enterprise Value as of March 2026 (TTM) for Aldeyra Therapeutics, Inc. (ALDX) is -54510836746024.00

According to Aldeyra Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -54510836746024.00. This represents a change of 300.01% compared to the average of -13627497359062.49 of the last 4 quarters.

Aldeyra Therapeutics, Inc. (ALDX) Historical Enterprise Value (quarterly & annually)

How has ALDX Enterprise Value performed in the past?

The mean historical Enterprise Value of Aldeyra Therapeutics, Inc. over the last ten years is -5450958559083.88. The current -54510836746024.00 Enterprise Value has changed 99.90% with respect to the historical average. Over the past ten years (40 quarters), ALDX's Enterprise Value was at its highest in in the March 2023 quarter at 434.88M. The Enterprise Value was at its lowest in in the December 2025 quarter at -54510773356835.86.

Aldeyra Therapeutics, Inc. (ALDX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aldeyra Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aldeyra Therapeutics, Inc. (ALDX) Average Enterprise Value

How has ALDX Enterprise Value performed in the past?

The current Enterprise Value of Aldeyra Therapeutics, Inc. (ALDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aldeyra Therapeutics, Inc. (ALDX) Enterprise Value vs. Peers

How is ALDX’s Enterprise Value compared to its peers?

Aldeyra Therapeutics, Inc.’s Enterprise Value is less than AC Immune S.A. (217.16M), less than Mereo BioPharma Group plc (13.33M), less than Silence Therapeutics plc (314.48M), less than Cellectis S.A. (300.97M), less than Genelux Corporation (94.74M), less than Contineum Therapeutics, Inc. Class A Common Stock (407.53M), less than Alto Neuroscience, Inc. (581.24M), less than Amarin Corporation plc (194.57M), less than Candel Therapeutics, Inc. (138.56M), less than Kyverna Therapeutics, Inc. (362.80M),

Build a custom stock screener for Aldeyra Therapeutics, Inc. (ALDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aldeyra Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aldeyra Therapeutics, Inc. (ALDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aldeyra Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.